- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05520346
Testing a Device for Automatically TRacking Urine and STool in an Inpatient HCT Setting (Project TRUST)
The purpose of this study is to determine whether a prototype toilet device that we have developed can accurately and automatically track human fluid output from renal and gastrointestinal systems in the hospital. The device includes components that can be outfitted onto existing toilets.
In this study, participants hospital room will be outfitted with the prototype toilet device. Participants will use the toilet as usual throughout the duration of their inpatient stay. Sometimes output will be measured by the device, and other times output will be measured manually by nurses.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Lauren Hill
- Phone Number: 919-668-2369
- Email: lauren.hill@duke.edu
Study Contact Backup
- Name: Amy Bush
- Phone Number: +1 919 668 1085
- Email: amy.bush@duke.edu
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27705
- Recruiting
- Duke University
-
Contact:
- Chenyu Lin
- Phone Number: 919-668-1000
- Email: chenyu.lin@duke.edu
-
Contact:
- Phone Number: +1 919 684 8964
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Scheduled to undergo an allogeneic or autologous hematopoietic stem cell transplant for any cancer or non-cancer illness through the Duke ABMT clinic
- Age 18-80 years
- Karnofsky Performance Scale KPS ≥ 70
- Able to read/write English
Exclusion Criteria:
- Inability to use toilet device due to physical constraints, e.g. waste excreted through stoma or catheter
- Physician recommendation that patient does not use standard urine/stool collection hat during days 1-2 of HCT conditioning
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Device
Patients use toilet device to measure fluid output and self-report event types
|
Device will be installed on toilet of patients will in hospital to measure all waste output.
|
No Intervention: Control
Collection in standard hats + nurses visually assessing fluid volumes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Mean absolute error of urine volume (in mL) as measured by device compared to standard of care nurse assessment
Time Frame: Up to 14 days
|
Up to 14 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Correlation between daily patient fluid balance (difference between fluid input and output in mL) as measured by device measurements or standard of care nurse assessment and the change in daily weight
Time Frame: Up to 14 days
|
Up to 14 days
|
Mean absolute error of urine volume (in mL) as measured by device
Time Frame: Up to 14 days
|
Up to 14 days
|
Time (in mins) spent handling/recording patient waste
Time Frame: First 3 days of patient's HCT conditioning
|
First 3 days of patient's HCT conditioning
|
Levels of chemotherapy drugs detectable on room surfaces as measured by surface testing
Time Frame: First 3 days of patient's HCT conditioning
|
First 3 days of patient's HCT conditioning
|
Time (in mins) between nurse logging of patient urination in electronic medical records and device-based logging of patient urination
Time Frame: Up to 14 days
|
Up to 14 days
|
Percent device can correctly identify diarrhea events
Time Frame: Up to 14 days
|
Up to 14 days
|
Percent of patients who indicated device satisfaction as measured by patient survey
Time Frame: Day 3 of HCT conditioning
|
Day 3 of HCT conditioning
|
Percent of nurses who perceived lower chemotherapy exposure as measured by survey
Time Frame: After transition to Stage 2 - about 3 days after patient begins HCT conditioning
|
After transition to Stage 2 - about 3 days after patient begins HCT conditioning
|
Percent of nurses who indicated device satisfaction as measured by nurse survey
Time Frame: After transition to Stage 2 - about 3 days after patient begins HCT conditioning
|
After transition to Stage 2 - about 3 days after patient begins HCT conditioning
|
Number of patient falls as measured by patient report
Time Frame: Up to 17 days
|
Up to 17 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Chenyu Lin, MD, Duke University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Pro00107848
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fluid Output
-
Imperial College LondonCompletedCardiac Output | Fluid ResponsivenessUnited Kingdom
-
Petrovsky National Research Centre of SurgeryCompletedFluid Overload | Cardiac Disease | Cardiac Output, Low | Volume Overload | Cardiac Output, High | Fluid LossRussian Federation
-
Samsung Medical CenterCompletedProne Position | Fluid Responsiveness | Non Invasive Cardiac Output MonitoringKorea, Republic of
-
Medical University of WarsawUnknownCardiac Output, Low | Body Fluid Retention | ImpedancePoland
-
Samsung Medical CenterWithdrawnFluid Responsiveness | Neurological Diseases or Conditions | Non Invasive Cardiac Output Monitoring | Gray ZoneKorea, Republic of
-
University of FloridaCompletedMortality | Acute Kidney Injury | Fluid Balance | Inflammatory Mediators | Input and OutputUnited States
-
HeartBeat Technologies LTDUnknownLow Cardiac Output | High Cardiac OutputIsrael
-
Université Libre de BruxellesCompleted
-
Centre Hospitalier Universitaire de BesanconUnknown
-
University of British ColumbiaCompleted
Clinical Trials on Electronic Device for Toilet
-
Seoul National University HospitalWoongjin Coway CorporationCompletedAnorectal PhysiologyKorea, Republic of
-
University of RochesterVanderbilt University; Nationwide Children's HospitalCompletedEnuresis | Autistic DisorderUnited States
-
Northwell HealthCompletedAutism Spectrum Disorder | Wandering BehaviorUnited States
-
Wicab Technologies (Beijing) Co., Ltd.Completed
-
Imperial College LondonAsthma UKCompletedAsthma in ChildrenUnited Kingdom
-
Assistance Publique - Hôpitaux de ParisCompletedCuff Overinflation | Cuff UnderinflationFrance
-
ALK-Abelló A/SCompletedAllergic Rhinitis | Grass AllergyItaly
-
Assistance Publique - Hôpitaux de ParisTerminated
-
Annecto LLCHoly Redeemer HospitalTerminatedMild to Moderate DepressionUnited States
-
ola mohamed elsayed mostafa elgoharyCairo UniversityUnknownPeripheral Arterial DiseaseEgypt